Sanofi's NKCE trial SAR443579 in AML halted early; results posted for terminated studyOct 23Weekly roundup, 6 itemsBayerdiclofenac
Lilly posts two DC-806 Phase 1 DDI results; registers three new Phase 3 trialsOct 22Weekly roundup, 11 itemscetuximabdulaglutide
Sanofi posts SAR444881 results; adds two rilzabrutinib trials and RSV AI studyOct 2Weekly roundup, 5 itemsrilzabrutinibSanofiUpdated
Sign inSign in